Loading...
Please wait, while we are loading the content...
Similar Documents
Ponatinib treatment promotes arterial thrombosis and hyperactive platelets
| Content Provider | Scilit |
|---|---|
| Author | Merkulova, Alona Mitchell, Steven C. Stavrou, Evi X. Forbes, Gabriel L. Schmaier, Alvin H. |
| Copyright Year | 2019 |
| Description | Key Points Ponatinib therapy heightens arterial thrombosis and platelet reactivity. Concurrent pioglitazone treatment reverses heightened thrombosis risk and platelet reactivity induced by ponatinib. |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693004/pdf |
| Ending Page | 2316 |
| Page Count | 5 |
| Starting Page | 2312 |
| DOI | 10.1182/bloodadvances.2019000034 |
| Journal | Blood advances |
| Issue Number | 15 |
| Volume Number | 3 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2019-08-05 |
| Access Restriction | Open |
| Subject Keyword | Hematology Arterial Thrombosis Thrombosis Risk Ponatinib Therapy Reactivity Induced Heightens Arterial Reverses Heightened Ponatinib Treatment Journal: Blood advances (Vol- 125, Issue- 15) |
| Content Type | Text |
| Resource Type | Article |